453 related articles for article (PubMed ID: 2498383)
1. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
2. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
3. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
[TBL] [Abstract][Full Text] [Related]
6. Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men.
Rosenbaum M; Fong YM; Hesse DG; Tracey KJ; Hintz RL; Lowry SF; Gertner JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):310-6. PubMed ID: 2502553
[TBL] [Abstract][Full Text] [Related]
7. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
[TBL] [Abstract][Full Text] [Related]
8. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
[TBL] [Abstract][Full Text] [Related]
9. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
[TBL] [Abstract][Full Text] [Related]
14. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
15. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
18. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
19. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.
Ocampo-Lim B; Guo W; DeMott-Friberg R; Barkan AL; Jaffe CA
J Clin Endocrinol Metab; 1996 Dec; 81(12):4396-9. PubMed ID: 8954048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
